Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp > BCTX Fast Track FDA Approval

<< Previous

Bullboard Posts

Next >>

Comment by HomerAndCompanyon Apr 14, 2022 8:42am

173 Views

Post# 34603123

RE:BCTX Fast Track FDA Approval

Sell off on great news after a run-up on no news!? What's going on? -TIA

LondonInvest wrote:
Well this week's options trading isn't at all suspicious! I am long so happy about great advancement for company on outstanding news, but someone definitely leaked something for all those options trades with 2 days left on contract. They make sense now.

https://finance.yahoo.com/news/briacell-receives-fda-fast-track-120000512.html